Huge recurrent gastric neuroendocrine tumor: a second-line chemotherapeutic dilemma
Chemotherapy is considered “state of the art” for the treatment of poorly differentiated neuroendocrine neoplasms. Unfortunately, there is no standard effective post-first-line treatment for relapsing high-grade gastroenteropancreatic neuroendocrine neoplasms. We report the case of a patient with a...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
University of São Paulo
2018-03-01
|
Series: | Autopsy and Case Reports |
Subjects: | |
Online Access: | http://www.revistas.usp.br/autopsy/article/view/147148 |